12th Mar 2010 12:01
Shares in Avesco ticked up after the provider of technical support for broadcasting and entertainment events said it had a successful Winter Olympics at Vancouver. 'With contracts in place over the summer for the FIFA World Cup and the World Expo in Shanghai, the Avesco group expects to trade profi
Read more7th Jan 2010 08:43
Drug developer Syntopix said it narrowed pre-tax losses in 2009 and is planning a share sale to fund the development of its products. Pre-tax loss narrowed to £1.26m for the year ended 31 July 2009 from a loss of £1.53m the year before. Turnover for the period increased to £190,000 from £141,000 th
Read more12th Nov 2009 17:00
Footsie hit a new intra-day high for the year in mid-afternoon, but buyer interest tailed off near the close as US markets retreated on a mild resurgence by the dollar. British Airways was the top performer after the airline confirmed it is holding meetings with Spanish airline Iberia to discuss th
Read more12th Nov 2009 14:32
Drug developer Syntopix shares rallied as it reported positive phase 2 results for its lead dermatological compound SYN0126, for the treatment of acneic skin. Following the results, Syntopix has decided to focus its development efforts around three specific core compounds: SYN0126, SYN1113 and SYN
Read more